Skip to main content Skip to main navigation menu Skip to site footer

The effectiveness of probiotic as adjuvant therapy of severe pneumonia in children below 5 years-old at Sanglah General Hospital, Bali, Indonesia

  • Yohannes Adinatha ,
  • Ida Bagus Subanada ,
  • I Made Arimbawa ,
  • Gusti Ayu Putu Nilawati ,
  • Eka Gunawijaya ,
  • I Nyoman Budi Hartawan ,


Abstract

Background: Pneumonia is a respiratory disease that can cause a lot of morbidity and mortality. Factors that associated with severe pneumonia in children include toddler age, malnutrition, male sex, exclusive breastfeeding, incomplete immunization. This study aims to evaluate the probiotic effectiveness as adjuvant therapy in childhood pneumonia compared to placebo.

Methods: This is a randomized, double-blind controlled trial among 54 children with severe pneumonia aged 2 months-5 years who received standard therapy and probiotics compared to standard therapy and placebo from August 2017 to July 2019. Both groups were evaluated for treatment outcomes after receiving 5 days of adjuvant therapy at Sanglah General Hospital, Bali, Indonesia which divided into Group I (n=27) (standard therapy and probiotics) and Group II (n=27) (standard therapy and placebo). Variables assessed in this study include the characteristic of subjects, length of stay, duration of fever, shortness of breath, retractions, rales, C-reactive protein (CRP), probiotics, and history of breastfeeding. Data were analyzed by SPSS version 20 for Windows. 

Results: Both groups were shown predominantly in male gender (66.67% and 59.26%), exclusive breastfeeding (88.89% and 77.78%), no malnutrition status (81.48% and 77.78%), and having complete immunization history (81.48% and 88.89%) in Group I and II, respectively. There was no statistically significant difference on the length of stay, length of fever, duration of the breath, length of subcostal retraction and decrease in CRP levels on both groups (p>0.05). Meanwhile, there was a statistical difference in rales duration (p=0.037). Multivariate analysis using Ancova found probiotics were able to reduce the duration of rales significantly by 5.87 hours (p=0.022; 95% CI: -10.89 – (-0.86)).

Conclusion: This study concluded that adjuvant therapy with probiotics significantly reduced rales duration in children with severe pneumonia.
Keywords: Severe Pneumonia Children Probiotic Effectiveness

References

  1. Pramana KP, Subanada IB. Hubungan jumlah leukosit serta kadar C-reactive Protein dengan derajat keparahan pneumonia anak. Medicina. 2015;46 (2):77-81.
  2. Djelantik IG, Gessner BD, Sutanto A, Steinhoff M, Linehan M, Moulton LH, et al. Case fatality proportions and predictive factors for mortality among children hospitalized with severe pneumonia in a rural developing country setting. J Trop Pediatr. 2003;49(6):327â€332.
  3. Karki S, Fitzpatrick AL, Shrestha S. Risk Factors for Pneumonia in Children under 5 Years in a Teaching Hospital in Nepal. Kathmandu Univ Med J (KUMJ). 2014;12(48):247â€252.
  4. Wang Y, Li X, Ge T, Xiao Y, Liao Y, Cui Y, et al. Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95(31):e4509.
  5. Day RL, Harper AJ, Woods RM, Davies OG, Heaney LM. Probiotics: current landscape and future horizons. Future Sci OA. 2019;5(4):FSO391.
  6. Forsythe P. Probiotics and lung diseases. Chest. 2011;139(4):901â€908.
  7. Bayer-Mulsid TB, Gatcheco FN. Randomized clinical trial on the effect of probiotic, ohhira omx capsules, as an adjunct in the treatment of severe pneumonia in patients 6-24 months of age. 3rd Asian Congress of Pediatric Infectious Diseases and 13th Pediatric Infectious Disease Society of The Philippines Annual Convention. 2006: 1-19 [Available from: http://www.omxprobiotika.cz/wp-content] [Accessed: June 2018]
  8. Esposito S, Rigante D, Principi N. Do children's upper respiratory tract infections benefit from probiotics?. BMC Infect Dis. 2014;14:194. Published 2014 Apr 10. doi:10.1186/1471-2334-14-194
  9. Becina PGA, Becina GT. A double–blinded, randomized, controlled trial of the efficacy of multiple strain probiotics as adjunct therapy for moderate risk community acquired pneumonia. PIDSP. 2014;15(2):10-18.
  10. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008;121(3):219â€225. doi:10.1016/j.amjmed.2007.10.033
  11. Subanada IB, Purniti NPS. Faktor-faktor yang berhubungan dengan pneumonia bakteri pada anak. Sari Pediatri. 2010;12(3):184-9.
  12. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, et al. Recommendations for probiotic use. J Clin Gastroenterol. 2006;40(3):275â€278.
  13. Araujo GV, Oliveira Junior MH, Peixoto DM, Sarinho ES. Probiotics for the treatment of upper and lower respiratory-tract infections in children: systematic review based on randomized clinical trials. J Pediatr (Rio J). 2015;91(5):413â€427.
  14. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009;124(2):e172â€e179. doi:10.1542/peds.2008-2666
  15. Skovbjerg S, Roos K, Holm SE, Hakansson EG, Nowrouzian F, Ivarsson M, et al. Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media. Arch Dis Child. 2009;94(2):92â€98.
  16. Kumpu M, Kekkonen RA, Kautiainen H, Jarvenpaa S, Kristo A, Huovinen P, et al. Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr. 2012;66(9):1020â€1023.
  17. Mazidi M, Rezaie P, Ferns GA, Vatanparast H. Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients. 2017;9(1):20.
  18. Asemi Z, Zare Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 2013;63(1-2):1â€9.
  19. Agrawal S, Rao S, Nathan EA, Patole S. Effect of probiotics on C-reactive protein levels in preterm infants: Secondary analysis of a randomized controlled trial. J Neonatal Perinatal Med. 2018;11(2):165â€171. doi:10.3233/NPM-181763
  20. Gottlieb M, Heinrich SA. How Reliable Are Signs and Symptoms for Diagnosing Pneumonia in Pediatric Patients?. Ann Emerg Med. 2018;71(6):725â€727.

How to Cite

Adinatha, Y., Subanada, I. B., Arimbawa, I. M., Nilawati, G. A. P., Gunawijaya, E., & Hartawan, I. N. B. (2020). The effectiveness of probiotic as adjuvant therapy of severe pneumonia in children below 5 years-old at Sanglah General Hospital, Bali, Indonesia. Bali Medical Journal, 9(1), 390–394. https://doi.org/10.15562/bmj.v9i1.1773
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
3

Total
27

Share

Search Panel

Yohannes Adinatha
Google Scholar
Pubmed
BMJ Journal

Ida Bagus Subanada
Google Scholar
Pubmed
BMJ Journal

I Made Arimbawa
Google Scholar
Pubmed
BMJ Journal

Gusti Ayu Putu Nilawati
Google Scholar
Pubmed
BMJ Journal

Eka Gunawijaya
Google Scholar
Pubmed
BMJ Journal

I Nyoman Budi Hartawan
Google Scholar
Pubmed
BMJ Journal